Prostate Cancer (cont.)
IN THIS ARTICLE
Prostate Cancer Evaluation and Diagnosis
Medical interview and physical examination:
A proper medical interview eliciting a thorough medical history and a physical examination are essential in the diagnostic workup of any man in whom prostate cancer is suspected. He may be referred to a physician who specializes in urinary tract diseases (a urologist) or in urinary tract cancers (a urologic oncologist). A man will be asked questions about his medical and surgical history, lifestyle and habits, and any medications he takes. Risk factors including family history of prostate cancer will be assessed (see prostate cancer risk factors).
Digital rectal examination (DRE) is part of the physical examination: All men with firm swelling, asymmetry, or palpable, discrete, firm areas or nodules in the prostate gland require further diagnostic studies to rule out prostate cancer, particularly if they are over the age of 45 or have other risk factors for the disease (see risk factors of prostate cancer).
Because urological symptoms (see prostate cancer symptoms) can indicate a variety of conditions, a man may undergo further testing to pinpoint their cause. Initial screening tests include blood testing for PSA and urine testing for blood or signs of infection.
Prostate specific antigen (PSA):
PSA is an enzyme produced by both normal and abnormal prostate tissues. It may be elevated in noncancerous conditions, such as prostatitis (inflammation of the prostate) and benign prostatic hypertrophy (noncancerous enlargement of the prostate), as well as in cancer of the prostate. Therefore, confirmation of an elevated serum PSA is advisable prior to proceeding to prostate biopsy.
PSA values over time may also be more helpful for monitoring recurrence of cancer and the response to treatment than in diagnosing a previously unknown cancer.
The following standards have been set for PSA levels:
Traditionally, a PSA of 4 ng/mL has been used as a cutoff value for deciding for or against doing a prostate biopsy. However, some experts now recommend lowering that to 2.5 ng/mL and performing the biopsy in men who have levels in excess of this threshold. The American Urological Association guidelines (2009) do not define a definite cutoff point but advise that all the other risk factors for prostate cancer be taken into account while making a decision on whether to proceed for a biopsy. One of the important factors that needs to be considered is the rate at which the PSA value has increased over time on repeated measurements (referred to as the PSA velocity).
Based upon the symptoms, physical examination, DRE and PSA level, further blood tests may include:
Medically Reviewed by a Doctor on 3/31/2015
YOU MAY ALSO LIKE
Must Read Articles Related to Prostate Cancer
Patient Comments & Reviews
The eMedicineHealth doctors ask about Prostate Cancer:
Prostate Cancer - Symptoms
The symptoms of prostate cancer can vary greatly from patient to patient. What were your symptoms at the onset of your disease?
Prostate Cancer - Diagnosis
How was your prostate cancer diagnosed?
Prostate Cancer - Treatment
What was the treatment for your prostate cancer?
Prostate Cancer - Prognosis
What is your prostate cancer prognosis?
Prostate Cancer - Surgery
Did you opt for surgery for your prostate cancer? Why or why not?
Health Solutions From Our Sponsors
Read What Your Physician is Reading on Medscape
Prostate cancer is the most common noncutaneous cancer among males.